<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(1)</volume><submitter>Wang Y</submitter><pubmed_abstract>Fungal immunoregulatory proteins (FIP) are effective small molecule proteins with broad-spectrum immunomodulatory and anti-cancer activities and can be potential agents for the development of clinical drugs and health food additives. In this study, a new member of FIP named FIP-bbo was obtained through Botryobasidium botryosum genome mining. FIP-bbo has the typical characteristics of FIP but is genetically distant from other FIPs. Recombinant FIP-bbo (rFIP-bbo) was produced in an optimized E. coli expression system, and the pure protein was isolated using a Ni-NTA column. Antineoplastic experiments suggested that FIP-bbo is similar to LZ-8 in inhibiting various cancer cells (Hela, Spac-1, and A549) at lower concentrations, but it is not as potent as LZ-8. The molecular mechanism by which F</pubmed_abstract><journal>Scientific reports</journal><pagination>5818</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6456589</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Identification of a Novel Anti-cancer Protein, FIP-bbo, from Botryobasidium botryosum and Protein Structure Analysis using Molecular Dynamic Simulation.</pubmed_title><pmcid>PMC6456589</pmcid><pubmed_authors>Gao YN</pubmed_authors><pubmed_authors>Bai R</pubmed_authors><pubmed_authors>Bao DP</pubmed_authors><pubmed_authors>Shang JJ</pubmed_authors><pubmed_authors>Chen HY</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wu YY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of a Novel Anti-cancer Protein, FIP-bbo, from Botryobasidium botryosum and Protein Structure Analysis using Molecular Dynamic Simulation.</name><description>Fungal immunoregulatory proteins (FIP) are effective small molecule proteins with broad-spectrum immunomodulatory and anti-cancer activities and can be potential agents for the development of clinical drugs and health food additives. In this study, a new member of FIP named FIP-bbo was obtained through Botryobasidium botryosum genome mining. FIP-bbo has the typical characteristics of FIP but is genetically distant from other FIPs. Recombinant FIP-bbo (rFIP-bbo) was produced in an optimized E. coli expression system, and the pure protein was isolated using a Ni-NTA column. Antineoplastic experiments suggested that FIP-bbo is similar to LZ-8 in inhibiting various cancer cells (Hela, Spac-1, and A549) at lower concentrations, but it is not as potent as LZ-8. The molecular mechanism by which F</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2026-04-29T16:00:31.892Z</modification><creation>2019-06-06T21:09:37Z</creation></dates><accession>S-EPMC6456589</accession><cross_references><pubmed>30967569</pubmed><doi>10.1038/s41598-019-42104-1</doi></cross_references></HashMap>